The Manufacturers Life Insurance Company Has $107.82 Million Position in IQVIA Holdings Inc. (NYSE:IQV)

The Manufacturers Life Insurance Company increased its stake in IQVIA Holdings Inc. (NYSE:IQV) by 0.9% in the 3rd quarter, Holdings Channel reports. The firm owned 454,984 shares of the medical research company’s stock after purchasing an additional 4,240 shares during the period. The Manufacturers Life Insurance Company’s holdings in IQVIA were worth $107,818,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. First Foundation Advisors lifted its holdings in shares of IQVIA by 3.8% during the second quarter. First Foundation Advisors now owns 1,161 shares of the medical research company’s stock worth $245,000 after buying an additional 43 shares during the last quarter. Invera Wealth Advisors LLC lifted its holdings in shares of IQVIA by 0.3% during the second quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company’s stock worth $3,183,000 after buying an additional 46 shares during the last quarter. Private Trust Co. NA lifted its holdings in shares of IQVIA by 10.7% during the third quarter. Private Trust Co. NA now owns 485 shares of the medical research company’s stock worth $115,000 after buying an additional 47 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its holdings in shares of IQVIA by 0.3% during the second quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company’s stock worth $3,313,000 after buying an additional 48 shares during the last quarter. Finally, Continuum Advisory LLC lifted its holdings in shares of IQVIA by 3.3% during the second quarter. Continuum Advisory LLC now owns 1,538 shares of the medical research company’s stock worth $325,000 after buying an additional 49 shares during the last quarter. 89.62% of the stock is currently owned by institutional investors and hedge funds.

IQVIA Price Performance

Shares of IQV stock opened at $201.24 on Wednesday. The stock’s fifty day moving average is $221.18 and its 200-day moving average is $226.75. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The stock has a market capitalization of $36.53 billion, a PE ratio of 26.41, a PEG ratio of 2.10 and a beta of 1.51. IQVIA Holdings Inc. has a 52 week low of $187.62 and a 52 week high of $261.73.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on IQV shares. Argus upgraded IQVIA to a “strong-buy” rating in a report on Wednesday, July 31st. Morgan Stanley cut their target price on IQVIA from $280.00 to $265.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. StockNews.com upgraded IQVIA from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Leerink Partners restated an “outperform” rating and issued a $248.00 target price (down from $260.00) on shares of IQVIA in a research note on Tuesday, November 19th. Finally, TD Cowen cut their target price on IQVIA from $270.00 to $255.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Four analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $256.50.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.